TY - JOUR
T1 - Adjuvant steroid to percutaneous needle fasciotomy for Dupuytrenʼs contracture. An RCT study protocol
AU - Matthiesen, Laura Houstrup
AU - Skov, Simon Toftgaard
AU - Lange, Jeppe
PY - 2024/11/12
Y1 - 2024/11/12
N2 - INTRODUCTION. Percutaneous needle fasciotomy (PNF) is a non-invasive treatment option for finger flexion contractures caused by Dupuytren’s disease. Variations in PNF techniques include the use of corticosteroid injection. In the presented randomised controlled trial, we compare the efficacy of PNF +/-corticosteroid injection in terms of reducing the recurrence rate. METHODS. This study is performed as a two-armed, randomised controlled trial with a two-year follow-up. Patients will be allocated 1:1 to either PNF with corticosteroid injection (n = 200) or PNF with saline injection (n = 200). Follow-up is conducted at 90 days, one year, and two years after treatment. A finger goniometer will be used to assess finger extension deficit. Treatment complications and adverse events will be recorded, and patient-reported outcomes will be registered utilizing hand-specific and quality-of-life questionnaires. CONCLUSIONS. This study is expected to be the first randomised controlled trial to compare PNF +/-single corticosteroid injection in a large cohort of patients with Dupuytren’s contracture. The results will contribute to evidence-based recommendations for the treatment of Dupuytren’s contracture.
AB - INTRODUCTION. Percutaneous needle fasciotomy (PNF) is a non-invasive treatment option for finger flexion contractures caused by Dupuytren’s disease. Variations in PNF techniques include the use of corticosteroid injection. In the presented randomised controlled trial, we compare the efficacy of PNF +/-corticosteroid injection in terms of reducing the recurrence rate. METHODS. This study is performed as a two-armed, randomised controlled trial with a two-year follow-up. Patients will be allocated 1:1 to either PNF with corticosteroid injection (n = 200) or PNF with saline injection (n = 200). Follow-up is conducted at 90 days, one year, and two years after treatment. A finger goniometer will be used to assess finger extension deficit. Treatment complications and adverse events will be recorded, and patient-reported outcomes will be registered utilizing hand-specific and quality-of-life questionnaires. CONCLUSIONS. This study is expected to be the first randomised controlled trial to compare PNF +/-single corticosteroid injection in a large cohort of patients with Dupuytren’s contracture. The results will contribute to evidence-based recommendations for the treatment of Dupuytren’s contracture.
UR - http://www.scopus.com/inward/record.url?scp=85210831789&partnerID=8YFLogxK
U2 - 10.61409/A05240324
DO - 10.61409/A05240324
M3 - Journal article
SN - 1603-9629
VL - 71
JO - Danish Medical Journal
JF - Danish Medical Journal
IS - 12
M1 - A05240324
ER -